Rationale, design, and baseline characteristics of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 left ventricular assist device recipients (ENVAD-HF)

ENVAD-HF is the first prospective randomized controlled trial of pharmacologic therapy for the management of BP in stable recipients with HM3 LVADs achieving target enrollment. It will provide data on safety, tolerability, and insights on efficacy of sacubitril/valsartan versus SOC used for treating BP.

Authors

Institutions

Publication Details

Journal
Journal of Cardiac Failure
Published
2025-08-15
DOI
https://doi.org/10.1016/j.cardfail.2025.07.015
Citations
2
Primary Topic
Mechanical Circulatory Support Devices
Type
article
Field-Weighted Citation Impact
1.35
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rationale, design, and baseline characteristics of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 left ventricular assist device recipients (ENVAD-HF)

Filip Lončarić, Nir Y. Uriel, Brian Lee Claggett, Frank Thomas Ruschitzka et al.
2 citations
Journal of Cardiac Failure
Mechanical Circulatory Support Devices
1.35
article

Rationale, design, and baseline characteristics of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 left ventricular assist device recipients (ENVAD-HF)

Filip Lončarić, Nir Y. Uriel, Brian Lee Claggett, Frank Thomas Ruschitzka, Ulrich P. Jorde, Jasper J. Brugts, Ivo Planinc, Markéta Hegarová, Linda W. van Laake, Mandeep R. Mehra, Filip Puškarić, Maja Čikeš, Nina Jakuš, Igor Rudež, Davor Miličić, Paweł Rubiś, Scott D. Solomon
article en
2 citations

Abstract

ENVAD-HF is the first prospective randomized controlled trial of pharmacologic therapy for the management of BP in stable recipients with HM3 LVADs achieving target enrollment. It will provide data on safety, tolerability, and insights on efficacy of sacubitril/valsartan versus SOC used for treating BP.

Journal of Cardiac FailureVol. 32(2)
Jagiellonian University (PL), Brigham and Women's Hospital (US), University Hospital Centre Zagreb (HR), University of Zagreb (HR), Columbia University Irving Medical Center (US), University Hospital Dubrava (HR), University Medical Center Utrecht (NL), University Hospital of Zurich (CH), John Paul II Hospital (PL), Montefiore Health System (US), Institute of Clinical and Experimental Medicine (CZ), Erasmus MC Cancer Institute (NL), Erasmus University Rotterdam (NL)
Openalex Percentile: Top 18%
Mechanical Circulatory Support Devices
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.